Cigna Corporation (CI) EBITDA Margin: 4.22%
Is Cigna Corporation’s EBITDA margin high or low?
Cigna Corporation's EBITDA margin of 4.22% is 22% below its 5-year average of 5.39%, near the low end of its 5-year range (4.22%–6.46%).
As of Wednesday, June 17, 2026. 4.63% below its 12-month average of 4.42%.
CI EBITDA Margin Chart
CI Average EBITDA Margin Chart
CI Current vs Average EBITDA Margin Chart
CI EBITDA Margin Metrics
EBITDA MARGIN
4.22%
EBITDA MARGIN AVG TTM
4.42%
EBITDA MARGIN AVG 3Y
5.04%
EBITDA MARGIN AVG 5Y
5.39%
EBITDA MARGIN AVG 10Y
7.27%
EBITDA MARGIN AVG 15Y
7.31%
EBITDA MARGIN AVG 20Y
7.30%
CURRENT VS TTM AVG
-4.63%
CURRENT VS 3Y AVG
-16.35%
CURRENT VS 5Y AVG
-21.76%
CURRENT VS 10Y AVG
-41.97%
CURRENT VS 15Y AVG
-42.23%
CURRENT VS 20Y AVG
-42.20%
CI Competitors' EBITDA Margin
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cigna Corporation (CI) | $76.25B | 4.22% | 4.42% | 5.04% | 5.39% |
| Boston Scientific Corporation (BSX)vs › | $69.74B | 25.42% | 24.47% | 23.70% | 21.87% |
| Elevance Health Inc. (ELV)vs › | $85.70B | 4.85% | 5.39% | 5.84% | 6.22% |
| HCA Healthcare, Inc. (HCA)vs › | $86.23B | 20.64% | 20.16% | 20.49% | 20.85% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $63.33B | 40.57% | 39.01% | 39.25% | 44.24% |
| Cencora, Inc. (COR)vs › | $54.76B | 1.16% | 1.15% | 1.23% | 0.63% |
| Cardinal Health, Inc. (CAH)vs › | $53.10B | 1.40% | 1.13% | 0.75% | 0.34% |
| Becton, Dickinson and Company (BDX)vs › | $52.59B | 22.70% | 23.29% | 23.17% | 22.44% |
| Medtronic plc (MDT)vs › | $103.29B | 26.97% | 27.23% | 26.91% | 26.72% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $45.20B | 34.13% | 33.43% | 32.56% | 31.99% |
Margin Comparison
Gross Margin
9.3%
EBITDA Margin
4.2%
Operating Margin
3.4%
Net Margin
2.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
- Removes effects of depreciation policies (D&A)
- Capital structure neutral (ignores interest)
- Tax neutral (ignores tax differences)
- Good proxy for operating cash generation
Cigna Corporation EBITDA Margin Formula & Definition
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cigna Corporation EBITDA Margin FAQ
- What is the EBITDA margin for Cigna Corporation (CI)?
- The EBITDA margin for CI stock is 4.22%.
- Is Cigna Corporation's EBITDA margin high or low?
- Cigna Corporation's EBITDA margin of 4.22% is 22% below its 5-year average of 5.39%, near the low end of its 5-year range (4.22%–6.46%).
- What is the TTM average EBITDA margin for Cigna Corporation (CI)?
- The TTM average EBITDA margin for CI stock is 4.42%.
- What is the 3Y average EBITDA margin for Cigna Corporation (CI)?
- The 3Y average EBITDA margin for CI stock is 5.04%.
- What is the 5Y average EBITDA margin for Cigna Corporation (CI)?
- The 5Y average EBITDA margin for CI stock is 5.39%.
- What is the 10Y average EBITDA margin for Cigna Corporation (CI)?
- The 10Y average EBITDA margin for CI stock is 7.27%.
- What is the 15Y average EBITDA margin for Cigna Corporation (CI)?
- The 15Y average EBITDA margin for CI stock is 7.31%.
- What is the 20Y average EBITDA margin for Cigna Corporation (CI)?
- The 20Y average EBITDA margin for CI stock is 7.30%.
Cigna Corporation EBITDA Margin History
| DATE | EBITDA MARGIN |
|---|---|
| 2025-12-31 | 4.22% |
| 2024-12-31 | 4.63% |
| 2023-12-31 | 5.55% |
| 2022-12-31 | 5.78% |
| 2021-12-31 | 5.72% |
| 2020-12-31 | 6.46% |
| 2019-12-31 | 7.54% |
| 2018-12-31 | 10.73% |
| 2017-12-31 | 10.47% |
| 2016-12-31 | 8.88% |
| 2015-12-31 | 10.02% |
| 2014-12-31 | 10.37% |
| 2013-12-31 | 1.84% |
| 2012-12-31 | 1.92% |
| 2011-12-31 | 11.63% |
| 2010-12-31 | 11.12% |
| 2009-12-31 | 12.66% |
| 2008-12-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2006-12-31 | 11.72% |
| 2005-12-31 | 12.07% |
| 2004-12-31 | 0.00% |
| 2003-12-31 | 6.11% |
| 2002-12-31 | 0.00% |
| 2001-12-31 | 0.00% |
| 2000-12-31 | 8.80% |
| 1999-12-31 | 0.00% |
| 1998-12-31 | 0.00% |
| 1997-12-31 | 0.00% |
| 1996-12-31 | 0.00% |
Related Metrics
About Cigna Corporation
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- David Michael Cordani